 Christopher Baker
Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tracheostomy | 19 | 2025 | 142 | 6.950 |
Why?
| | Bronchopulmonary Dysplasia | 32 | 2025 | 411 | 6.520 |
Why?
| | Respiration, Artificial | 23 | 2026 | 713 | 5.030 |
Why?
| | Home Care Services | 8 | 2025 | 284 | 2.050 |
Why?
| | Infant, Premature | 20 | 2025 | 619 | 1.940 |
Why?
| | Ventilator Weaning | 5 | 2024 | 40 | 1.660 |
Why?
| | Respiratory Insufficiency | 5 | 2024 | 326 | 1.580 |
Why?
| | Infant, Newborn | 39 | 2025 | 6447 | 1.400 |
Why?
| | Ventilators, Mechanical | 8 | 2025 | 71 | 1.300 |
Why?
| | Patient Discharge | 8 | 2025 | 992 | 1.250 |
Why?
| | Tracheobronchomalacia | 3 | 2025 | 15 | 1.100 |
Why?
| | Infant | 31 | 2026 | 10077 | 1.080 |
Why?
| | Infant, Premature, Diseases | 2 | 2021 | 113 | 0.970 |
Why?
| | Continuity of Patient Care | 3 | 2017 | 297 | 0.920 |
Why?
| | Patient Care Team | 5 | 2024 | 696 | 0.910 |
Why?
| | Fetal Blood | 5 | 2016 | 327 | 0.880 |
Why?
| | Child | 34 | 2026 | 22707 | 0.880 |
Why?
| | Trachea | 2 | 2026 | 258 | 0.880 |
Why?
| | Premature Birth | 5 | 2024 | 388 | 0.870 |
Why?
| | Length of Stay | 2 | 2024 | 1349 | 0.860 |
Why?
| | Respiratory Tract Diseases | 2 | 2022 | 175 | 0.780 |
Why?
| | Stem Cells | 3 | 2013 | 628 | 0.750 |
Why?
| | Tracheomalacia | 1 | 2022 | 17 | 0.720 |
Why?
| | Infant, Extremely Premature | 4 | 2022 | 68 | 0.710 |
Why?
| | Tracheoesophageal Fistula | 1 | 2022 | 40 | 0.700 |
Why?
| | Enteral Nutrition | 1 | 2024 | 217 | 0.690 |
Why?
| | Device Removal | 3 | 2019 | 142 | 0.670 |
Why?
| | Airway Extubation | 2 | 2019 | 60 | 0.670 |
Why?
| | Humans | 71 | 2026 | 145475 | 0.660 |
Why?
| | Deglutition Disorders | 1 | 2022 | 154 | 0.640 |
Why?
| | Feeding and Eating Disorders | 1 | 2022 | 164 | 0.610 |
Why?
| | Lung | 8 | 2025 | 4106 | 0.610 |
Why?
| | Respiratory Tract Fistula | 1 | 2019 | 7 | 0.600 |
Why?
| | Cutaneous Fistula | 1 | 2019 | 14 | 0.600 |
Why?
| | Tracheal Diseases | 1 | 2019 | 15 | 0.590 |
Why?
| | Child, Preschool | 18 | 2026 | 11853 | 0.580 |
Why?
| | Hypertension, Pulmonary | 6 | 2024 | 1957 | 0.580 |
Why?
| | Pediatrics | 4 | 2024 | 1121 | 0.580 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 107 | 0.550 |
Why?
| | Endothelial Cells | 4 | 2013 | 874 | 0.540 |
Why?
| | Caregivers | 4 | 2025 | 1073 | 0.520 |
Why?
| | Positive-Pressure Respiration | 4 | 2025 | 115 | 0.500 |
Why?
| | Pulmonary Alveoli | 3 | 2018 | 385 | 0.500 |
Why?
| | Pamphlets | 1 | 2016 | 26 | 0.490 |
Why?
| | Endothelial Progenitor Cells | 1 | 2016 | 20 | 0.490 |
Why?
| | Animals, Newborn | 3 | 2015 | 891 | 0.480 |
Why?
| | Curriculum | 3 | 2021 | 1070 | 0.480 |
Why?
| | Clinical Competence | 2 | 2024 | 1243 | 0.480 |
Why?
| | Airway Obstruction | 2 | 2021 | 153 | 0.480 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2016 | 78 | 0.470 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 116 | 0.470 |
Why?
| | Internship and Residency | 2 | 2024 | 1267 | 0.460 |
Why?
| | Simulation Training | 1 | 2017 | 135 | 0.440 |
Why?
| | Hyperoxia | 3 | 2013 | 96 | 0.430 |
Why?
| | Lung Diseases | 1 | 2021 | 780 | 0.430 |
Why?
| | Neovascularization, Physiologic | 2 | 2013 | 192 | 0.430 |
Why?
| | Clinical Protocols | 1 | 2016 | 280 | 0.420 |
Why?
| | Pre-Eclampsia | 1 | 2016 | 206 | 0.410 |
Why?
| | Human Umbilical Vein Endothelial Cells | 2 | 2022 | 104 | 0.410 |
Why?
| | Central Nervous System Diseases | 1 | 2014 | 74 | 0.400 |
Why?
| | Self Care | 1 | 2016 | 390 | 0.400 |
Why?
| | Organogenesis | 1 | 2014 | 63 | 0.400 |
Why?
| | Neovascularization, Pathologic | 1 | 2015 | 286 | 0.390 |
Why?
| | Culture Media, Conditioned | 1 | 2013 | 112 | 0.380 |
Why?
| | Bronchitis, Chronic | 1 | 2012 | 16 | 0.370 |
Why?
| | Umbilical Cord | 1 | 2013 | 93 | 0.370 |
Why?
| | Female | 30 | 2025 | 78845 | 0.370 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2013 | 59 | 0.360 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1923 | 0.360 |
Why?
| | Regeneration | 1 | 2014 | 197 | 0.360 |
Why?
| | Bleomycin | 1 | 2013 | 255 | 0.340 |
Why?
| | Quality Improvement | 2 | 2017 | 1295 | 0.340 |
Why?
| | Developmental Disabilities | 1 | 2014 | 281 | 0.340 |
Why?
| | Interleukin-8 | 1 | 2012 | 269 | 0.340 |
Why?
| | Patient Education as Topic | 1 | 2016 | 777 | 0.340 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 439 | 0.330 |
Why?
| | Sputum | 1 | 2012 | 302 | 0.320 |
Why?
| | Male | 25 | 2025 | 72843 | 0.320 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2013 | 221 | 0.310 |
Why?
| | Ambulatory Care | 3 | 2024 | 609 | 0.310 |
Why?
| | Pulmonary Medicine | 2 | 2024 | 78 | 0.310 |
Why?
| | Algorithms | 2 | 2025 | 1845 | 0.300 |
Why?
| | Hospital Mortality | 1 | 2014 | 1038 | 0.300 |
Why?
| | Communication | 1 | 2016 | 975 | 0.300 |
Why?
| | Acute Lung Injury | 1 | 2013 | 305 | 0.300 |
Why?
| | Argyria | 1 | 2007 | 4 | 0.270 |
Why?
| | Tomography | 2 | 2025 | 45 | 0.260 |
Why?
| | Silver | 1 | 2007 | 36 | 0.260 |
Why?
| | Retrospective Studies | 11 | 2025 | 17291 | 0.260 |
Why?
| | Skin Pigmentation | 1 | 2007 | 48 | 0.260 |
Why?
| | Neutrophils | 1 | 2012 | 1124 | 0.250 |
Why?
| | Postoperative Complications | 1 | 2019 | 2970 | 0.240 |
Why?
| | Morbidity | 3 | 2022 | 322 | 0.240 |
Why?
| | Chronic Disease | 3 | 2021 | 1808 | 0.230 |
Why?
| | Specimen Handling | 1 | 2026 | 182 | 0.210 |
Why?
| | Pylorus | 1 | 2024 | 17 | 0.210 |
Why?
| | Pregnancy | 5 | 2021 | 7202 | 0.200 |
Why?
| | Cells, Cultured | 4 | 2016 | 4148 | 0.200 |
Why?
| | Adolescent | 6 | 2024 | 22530 | 0.190 |
Why?
| | Colorado | 3 | 2024 | 4554 | 0.180 |
Why?
| | Air Pollution, Indoor | 1 | 2024 | 171 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2025 | 254 | 0.180 |
Why?
| | von Willebrand Diseases | 1 | 2022 | 28 | 0.180 |
Why?
| | von Willebrand Factor | 1 | 2022 | 85 | 0.170 |
Why?
| | Insufflation | 1 | 2021 | 14 | 0.170 |
Why?
| | Risk Factors | 4 | 2024 | 10885 | 0.170 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2021 | 18 | 0.170 |
Why?
| | Education, Medical, Graduate | 2 | 2024 | 562 | 0.170 |
Why?
| | Societies, Medical | 1 | 2025 | 899 | 0.170 |
Why?
| | United States | 7 | 2025 | 16098 | 0.170 |
Why?
| | Pulmonary Ventilation | 1 | 2021 | 82 | 0.160 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2025 | 779 | 0.160 |
Why?
| | Flow Cytometry | 2 | 2016 | 1162 | 0.160 |
Why?
| | Social Determinants of Health | 1 | 2024 | 308 | 0.160 |
Why?
| | Steroids | 2 | 2022 | 160 | 0.160 |
Why?
| | Aftercare | 1 | 2021 | 222 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 2 | 2013 | 574 | 0.150 |
Why?
| | Tracheotomy | 1 | 2019 | 23 | 0.150 |
Why?
| | Influenza Vaccines | 1 | 2024 | 534 | 0.150 |
Why?
| | Echocardiography | 2 | 2024 | 647 | 0.150 |
Why?
| | Emergencies | 1 | 2020 | 174 | 0.150 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2022 | 291 | 0.150 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 19 | 0.140 |
Why?
| | Influenza, Human | 1 | 2024 | 624 | 0.140 |
Why?
| | Polysomnography | 1 | 2019 | 239 | 0.140 |
Why?
| | Dental Cements | 1 | 2017 | 20 | 0.130 |
Why?
| | Cystic Fibrosis | 1 | 2007 | 1161 | 0.130 |
Why?
| | Transitional Care | 1 | 2017 | 45 | 0.130 |
Why?
| | Age Factors | 1 | 2024 | 3342 | 0.120 |
Why?
| | Cell Proliferation | 3 | 2013 | 2507 | 0.120 |
Why?
| | Infant Care | 1 | 2016 | 44 | 0.120 |
Why?
| | Long-Term Care | 1 | 2017 | 118 | 0.120 |
Why?
| | Expectorants | 1 | 2016 | 23 | 0.120 |
Why?
| | Young Adult | 3 | 2019 | 14219 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3413 | 0.120 |
Why?
| | Interrupted Time Series Analysis | 1 | 2016 | 75 | 0.120 |
Why?
| | Computer Simulation | 1 | 2020 | 1003 | 0.120 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2015 | 181 | 0.120 |
Why?
| | Prospective Studies | 3 | 2024 | 8057 | 0.120 |
Why?
| | Adrenal Cortex Hormones | 2 | 2018 | 484 | 0.110 |
Why?
| | Tidal Volume | 1 | 2016 | 109 | 0.110 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 558 | 0.110 |
Why?
| | Rats | 2 | 2015 | 5584 | 0.110 |
Why?
| | Diuretics | 1 | 2015 | 68 | 0.110 |
Why?
| | Adrenergic beta-Agonists | 1 | 2015 | 92 | 0.110 |
Why?
| | Carbon Dioxide | 1 | 2016 | 227 | 0.100 |
Why?
| | Time Factors | 3 | 2024 | 7123 | 0.100 |
Why?
| | Electronic Health Records | 1 | 2022 | 1196 | 0.100 |
Why?
| | Gestational Age | 3 | 2025 | 987 | 0.100 |
Why?
| | Monitoring, Physiologic | 1 | 2016 | 288 | 0.100 |
Why?
| | Electric Impedance | 2 | 2025 | 108 | 0.100 |
Why?
| | Hernia, Diaphragmatic | 1 | 2013 | 67 | 0.100 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 200 | 0.090 |
Why?
| | Leukocyte Count | 1 | 2013 | 316 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2024 | 11772 | 0.090 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2013 | 140 | 0.090 |
Why?
| | Vascular Diseases | 1 | 2015 | 252 | 0.090 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 664 | 0.090 |
Why?
| | Survival Rate | 1 | 2016 | 2090 | 0.080 |
Why?
| | Surveys and Questionnaires | 4 | 2025 | 6066 | 0.080 |
Why?
| | Survival Analysis | 1 | 2014 | 1374 | 0.080 |
Why?
| | Blotting, Western | 1 | 2013 | 1179 | 0.080 |
Why?
| | Maternal Exposure | 1 | 2012 | 189 | 0.080 |
Why?
| | Prevalence | 3 | 2025 | 2865 | 0.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 919 | 0.080 |
Why?
| | Risk | 1 | 2012 | 919 | 0.070 |
Why?
| | Outpatients | 2 | 2023 | 447 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5423 | 0.070 |
Why?
| | Risk Assessment | 1 | 2017 | 3747 | 0.070 |
Why?
| | Colloids | 1 | 2007 | 59 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2524 | 0.060 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1127 | 0.060 |
Why?
| | Animals | 3 | 2015 | 38030 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 552 | 0.060 |
Why?
| | Complementary Therapies | 1 | 2007 | 95 | 0.060 |
Why?
| | Gentian Violet | 1 | 2026 | 4 | 0.060 |
Why?
| | Phenazines | 1 | 2026 | 17 | 0.060 |
Why?
| | Biomarkers | 1 | 2017 | 4295 | 0.060 |
Why?
| | Antioxidants | 1 | 2009 | 550 | 0.060 |
Why?
| | Respiratory Therapy | 1 | 2024 | 25 | 0.050 |
Why?
| | Nitric Oxide | 1 | 2009 | 892 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4560 | 0.050 |
Why?
| | Phenotype | 2 | 2025 | 3155 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 195 | 0.050 |
Why?
| | Sleep Apnea Syndromes | 1 | 2024 | 98 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2025 | 2930 | 0.050 |
Why?
| | Adult | 2 | 2016 | 40777 | 0.050 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2022 | 35 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2024 | 544 | 0.050 |
Why?
| | Weibel-Palade Bodies | 1 | 2022 | 6 | 0.050 |
Why?
| | Child Day Care Centers | 1 | 2022 | 44 | 0.050 |
Why?
| | Program Development | 1 | 2024 | 368 | 0.040 |
Why?
| | Tobacco Smoke Pollution | 1 | 2024 | 227 | 0.040 |
Why?
| | Gastroesophageal Reflux | 1 | 2024 | 237 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2024 | 969 | 0.040 |
Why?
| | Lung Volume Measurements | 1 | 2021 | 46 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2024 | 1327 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2022 | 244 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2022 | 637 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 362 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2024 | 867 | 0.030 |
Why?
| | Mice | 1 | 2015 | 18329 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2953 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 1111 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 193 | 0.030 |
Why?
| | Societies | 1 | 2016 | 40 | 0.030 |
Why?
| | Vaccination | 1 | 2024 | 1426 | 0.030 |
Why?
| | Respiration | 1 | 2016 | 206 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1891 | 0.030 |
Why?
| | Parents | 1 | 2024 | 1403 | 0.030 |
Why?
| | Education, Medical, Continuing | 1 | 2016 | 133 | 0.030 |
Why?
| | Indiana | 1 | 2015 | 38 | 0.030 |
Why?
| | Fundoplication | 1 | 2015 | 52 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1082 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2022 | 1581 | 0.030 |
Why?
| | Infant, Low Birth Weight | 1 | 2015 | 156 | 0.030 |
Why?
| | Schools, Medical | 1 | 2015 | 159 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2015 | 571 | 0.020 |
Why?
| | Gastrostomy | 1 | 2015 | 130 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5905 | 0.020 |
Why?
| | Software | 1 | 2017 | 680 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 653 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 785 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2017 | 1407 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 2018 | 910 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 95 | 0.020 |
Why?
| | Cell Shape | 1 | 2009 | 56 | 0.020 |
Why?
| | Air | 1 | 2009 | 44 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 2134 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 86 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2009 | 203 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2769 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2923 | 0.020 |
Why?
| | Signal Transduction | 1 | 2009 | 5216 | 0.010 |
Why?
|
|
Baker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|